Protocol Ledger

NCT07100990 · Phase III · RECRUITING

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

Interventional Phase III clinical trial protocol NCT07100990 sponsored by Mayo Clinic in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-07-11 Enrollment: 382 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07100990
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)382 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07100990
Protocol FieldVerified Registry Value
NCT IdentifierNCT07100990
Consolidated Lead SponsorMayo Clinic
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment382 participants (ESTIMATED)
Registered Start Date2025-07-11
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07100990
Hospital Research SiteLocationSite Profile
University of Alabama at BirminghamBirmingham, ALOpen Hospital Dossier ->
Mayo Clinic ArizonaPhoenix, AZOpen Hospital Dossier ->
Loma Linda University Medical CenterLoma Linda, CAOpen Hospital Dossier ->
UC Davis Comprehensive Cancer CenterSacramento, CAOpen Hospital Dossier ->

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Mayo Clinic across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI